Next Article in Journal
Comparative Analyses of Cytochrome P450s and Those Associated with Secondary Metabolism in Bacillus Species
Next Article in Special Issue
Anti-inflammatory and Neuroprotective Effects of Fungal Immunomodulatory Protein Involving Microglial Inhibition
Previous Article in Journal
Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma
Previous Article in Special Issue
Kaempferia parviflora Extract as a Potential Anti-Acne Agent with Anti-Inflammatory, Sebostatic and Anti-Propionibacterium acnes Activity
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 19
Issue 11
10.3390/ijms19113622
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Dichloromethane Extracts of Geranium Koreanum Kom. Alleviates Esophagus Damage in Acute Reflux Esophagitis-Induced Rats by Anti-Inflammatory Activities

by
Hyeon Hwa Nam
,
Li Nan
and
Byung Kil Choo
*
Department of Crop Science & Biotechnology, Chonbuk National University, Jeonju 54896, Korea
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(11), 3622; https://doi.org/10.3390/ijms19113622
Submission received: 30 September 2018 / Revised: 5 November 2018 / Accepted: 14 November 2018 / Published: 16 November 2018
(This article belongs to the Special Issue Natural Anti-Inflammatory Agents 2018)
Browse Figures
Versions Notes

Abstract

:
Reflux esophagitis (RE) is a gastrointestinal disease caused by the reflux of gastric acid and stomach contents, and it leads to esophageal damage. Therefore, it is necessary to study the improvement of esophageal damage on a RE-induced model. The present study was accomplished to demonstrate the protective effects of a dichloromethane fraction of Geranium koreanum (DGK) plant on esophageal damage in an acute RE rat model. First, we examined the potential of anti-inflammatory effects of various fractions measured by cell cytotoxicity, morphological changes and nitric oxide (NO) production on lipopolysaccharide (LPS)-induced Raw 264.7 macrophage cells. Then, to evaluate the protective effects on RE, rats were partitioned into the following groups: normal control, RE-induced control and RE rats pre-treated with DGK 100 and 200 mg/kg body weight. The esophageal mucosal ulcer ratio was measured by the Image J program and histological changes were examined using a hematoxylin and eosin staining of the esophageal mucosa. The expression of pro-inflammatory proteins, cytokines and tight junction proteins involved in the esophageal mucosal damage were investigated using Western blotting and an enzyme-linked immunosorbent assay (ELISA) kit with esophagus tissue. DGK chemical profile and phenolic contents were analyzed by liquid chromatography-mass spectrometry (LC-MS/MS). The results showed that DGK exhibited anti-inflammatory effects against LPS-stimulated cells by significantly inhibiting NO production. Additionally, the results in vivo showed that improvement effects of DGK on esophageal mucosal damage. The expression of inflammatory proteins involved in nuclear factor κB (NF-κB) signaling pathways and tight junction protein (claudin-4 and -5) were significantly decreased in esophageal mucosa. We found the potential of DGK as source of replacement therapy products for inflammatory and RE disease.

Graphical Abstract

1. Introduction

Gastroesophageal reflux disease (GERD) is usually induced by the reflux of gastric acid or stomach contents into the esophagus due to a defection of the lower esophageal sphincter and it related to unphysiological stress, excessive drinking, smoking, sleeping position, crapulence, and Westernization of the lifestyle and diet. Reflux esophagitis (RE) causes symptoms such as heartburn, nausea, chronic cough, pharyngeal pain and asthma and may lead to complication of Barrett esophagus, esophagus stenosis and esophageal cancer when the disease continues for a long time [1,2,3,4]. Proton pump inhibitors (PPIs) and histamine receptor antagonist forms of treatment have been widely used for rapid relief of symptoms and mucosal injury in patients with reflux disease, but these drugs cause many complications and are resistant to long-term use [5,6]. Therefore, recent research studies have focused on the development of safer alternatives that could be effective in the treatment of gastroesophageal disease. According to previous studies, herbal extracts act through various biological mechanism because they contain a wide range of bioactive compounds. It was reported that protective effects of herbal extracts on tissue damage are attributed to cellular defense mechanisms such as an inflammation and oxidative stress responses [7,8,9].
Inflammatory responses and tissue damage, the part of the physiological innate defense system that maintains immune homeostasis, are induced by inflammatory mediators [10,11,12]. Recently, reports about an inflammation such as mucosal damage in the esophagus due to reflux have been published. Souza et al. [13] demonstrated the pro-inflammatory chemokines secreted by reflux of gastric juice in the esophageal squamous epithelial cells. In addition, increased pro-inflammatory proteins such as tumor necrosis factor alpha (TNF-α), inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) along with epithelium damage have been established in the esophageal tissue [14,15]. In addition, inflammatory changes associated with the pathogenesis of esophageal damage are induced by the release of gastric acid, which was found to be significantly increased in patients with RE [16,17].
Claudin, an integral membrane tight junction protein, functions as a barrier and maintains the polarity of epithelial cells. The changes of claudin protein expression have been demonstrated not only endothelium but numerous other cells and tissues, such as Schwann cells, olfactory epithelium, bowel mucosa, vascular endothelium, gastric cancer tissue and esophageal mucosa [18,19,20,21,22,23]. And, in the impaired mucosa, the loss of claudin proteins indicated by pro-inflammatory mediators induced cells or impaired mucosa.
Geranium koreanum Kom. is perennial plant from the Geraniaceae family and grows the Korean and northeast China. Geranium species have several phenolic compounds and commonly used as a conventional medicine to treat a various injury and symptoms such as diarrhea, itching, stomachic, intestinal inflammation and liver disorder, and antibacterial and hepatoprotective effects of Geranium koreanum extracts have been demonstrated [14,15,24,25]. Geraniin is the main polyphenolic compounds isolated from various Geranium species and is an important Chinese herbal medicine [26]. Previous studies have demonstrated that geraniin component has a wide range of pharmacological actions, including radioprotective, antioxidant, antitumor and inhibition effect on NF-κB activity [7,8,27,28]. Although the studies on for the beneficial anti-inflammatory effects of Geranium and Geraniin have been reported, none has sufficiently described the effect of Geranium korenum on esophageal damage.
Therefore, the aim of the present study is to find the bioactive fraction in Geranium koreanum extracts and demonstrate the relive effect of fraction on esophageal tissue damage by recovering tight junction proteins and anti-inflammatory activities through the NF-κB signaling pathways. The anti-inflammatory effects of hexane (HEX), dichloromethane (DICHO), ethyl acetate (EA) and butanol (BUT) fractions were measured by morphological change, cell viability, NO and iNOS production in Raw 264.7 macrophage cells. In addition, we investigated the effect of DGK through gross esophageal damage ratio, histopathology analysis, and inflammatory protein expression analysis on the inflamed esophagus in experimental RE models.

2. Results

2.1. Cell Viability and Optical Morphological Transformation in Raw 264.7 Cells

To identified the cytotoxicity of HEX, DICHO, EA and BUT fraction of Geranium koreanum, we analyzed the cell viability on Raw 264.7 macrophage cells treated with LPS (1 µg/mL) for 24 h using a cytotoxicity assay kit. The result showed that HEX, DICHO, EA and BUT fractions were not cytotoxicity against LPS-induced Raw 264.7 cells at concentrations of 100 and 200 µg/mL (Figure 1b). In the EA fraction, cell viability was slightly decreased compared to normal cells. Inflammation in LPS-induced Raw 264.7 macrophage cells lead to morphological changes, while untreated cells and samples kept their normal shape. We then investigated the potential effects of solvents fraction of Geranium koreanum on LPS (1 µg/mL)-induced transformation of Raw 264.7 cell morphology using a light microscope. LPS-induced inflammation significantly transformed the cell morphology, compared with that of normal cells cultured in a medium alone. Cells pre-treated with solvent fraction of Geranium koreanum (100 and 200 µg/mL), followed by LPS showed fewer transformed cells than the LPS treatment group (Figure 1a). In particular, the cells pre-treated with DICHO fraction demonstrated the most normal cell shape, compared with other fractions.

2.2. Effect of Geranium koreanum on Nitric Oxide (NO) Production and Inducible Nitric Oxide Synthase (iNOS) Expression in Lipopolysaccharide (LPS)-Induced in Raw 264.7 Cells

We measured production of NO, a pro-inflammatory mediator, to determine whether the solvent fraction of Geranium koreanum had anti-inflammatory effects. NO plays a significant role in immune defenses and it is produced by iNOS during inflammatory responses in the cell or tissue [12]. The cells were pre-treated with the HEX, DICHO, EA and BUT fraction at concentrations of 100 and 200 µg/mL for 1 h, followed by LPS (1 µg/mL) treatment for 24 h. As shown in Figure 2, the NO production was hardly observed in the normal group, compared with in the LPS-treated group. In the cells pre-treated with the all solvent fractions of Geranium koreanum (100 and 200 µg/mL), NO production was significantly inhibited in cells treated with DICHO fraction of Geranium koreanum (100 and 200 µg/mL), compared with the LPS treated group; the effects were concentration-dependent. In particular, NO production decreased the most (56% and 89%) in cells treated with DICHO fraction (100 and 200 µg/mL) of Geranium koreanum. Also, expression of the pro-inflammatory mediator iNOS protein was significantly decreased in cells treated with DICHO fraction 200 µg/mL.

2.3. Improvement of Esophageal Mucosal Damage in Acute Reflux Esophagitis (RE) Rats

To evaluate the protective effects of DGK on RE rats, experimental rats received DGK (100 and 200 mg/kg body weight) orally 90 min before the surgery. Rats, except for those in the normal control group, were subjected to laparotomies to ligate the pylorus and the junction between the forestomach and the corpus [29]. Gastric acid reflux induced esophageal damage during the ligation. Esophageal tissue in the RE control group (untreated with sample) showed tissue damage (black and red color) and hemorrhage induced by inflammation, compared with those in the normal control group (Figure 3). The esophageal erosion area of rats in the RE + DGK200 (200 mg/kg) group significantly decreased (>68%) compared with that in the RE control group. Therefore, these results indicate that the DGK has protective effects against esophageal mucosal damage in acute RE rats.

2.4. Histopathology Analysis of Esophagus of RE Rats

Esophageal tissue stained with hematoxylin and eosin showed no microscopic mucosal changes in normal control while more severe damages such as inflammatory cell infiltration, squamous cells, and a thin epithelial layer were observed in the mucosa and submucosa of the RE-induced rats. However, we observed that the esophagus damage of the RE rats was reduced to a similar condition to that of the normal control group by treatment with 200 mg/kg DGK. (Figure 4).

2.5. Inflammation-Related Protein Expression in Esophagus

Transcription factor NF-κB, which consists of p50 and p65, is the main regulator of the pro-inflammatory protein producing including iNOS, COX-2, cytokines TNF-α and interleukin-1β (IL-1β) during immune responses following its dissociation and phosphorylation by IκB-α. We identified pro-inflammatory mediators in the esophageal tissue by enzyme-linked immunosorbent assay (ELISA) kit and Western blotting to elucidate the expression of inflammatory proteins in inflamed tissue. In the ELISA assay, DGK showed inhibitory effect of the IL-1β and TNF-α protein increase on inflamed tissue (Figure 5a,b). Moreover, this inhibitory effect of DGK on the pro-inflammatory cytokines expression level were confirmed by western blot assay (Figure 5e,f). Phosphorylated-IκB-α (in the cytoplasm) and phosphorylated-p65 (in the nuclei) levels in the RE control group increased more than in the normal control group as a result of mucosal damage. Also, RE treatment increased pro-inflammatory protein expression, including COX-2, IL-1β, and TNF-α. DGK200 (200 mg/kg) improved esophageal inflammation by suppressing the expression of cytosolic p-IκB-α and nuclear p-p65 protein. In addition, DGK significantly reduced the increased expression of COX-2, TNF-α, and IL-1β protein, especially at 200 mg/kg (Figure 5c–i).

2.6. Claudin-4 and -5 Protein Expression in the Esophagus

Claudin, one of the tight junction protein in the epithelium and endothelium, exert a critical barrier function of the tight junction. In particular, claudin-4 and claudin-5 play an important role because of their tightening or sealing functions in a tissue [21,30]. We observed the effects of DGK on tight junction proteins of the esophageal mucosa in an RE rat model (Figure 6a–c). In a previous study, as esophageal erosions decreased, the expression of claudin proteins increased in the esophageal mucosa of a rat model of with GERD [30]. However, the expression of claudin-4 and claudin-5 was increased in pre-treated DGK 200 mg/kg group in a concentration-dependent manner and was significantly higher than the expression in the RE control group.

2.7. Identifying Polyphenolic Compounds Using Liquid Chromatography-Mass Spectrometry (LC-MS/MS)

The polyphenolic profile of DGK was determined by liquid chromatography-mass spectrometry (LP-MS/MS). The comprehensive evaluation of DICHO fraction polyphenols allowed the identification of various compounds, the result shows the compounds separated by LC-MS/MS. The main compounds reported from Geranium koreanum was identified as Geraniin (retention time 7.68 min) (Figure 7). The detected compounds presented in Table 1. Based on the above data, the presence of the following compounds was identified in the DGK: ellagitannin (compounds 1, 6, 8, 10, 11), triterpenoid (compound 4), glycoside (compounds 2, 3, 9), and tannin (compound 7).

3. Discussion

In the present study, we found that DGK has anti-inflammatory effects via inhibition of NO production and iNOS protein expression in the LPS-induced macrophage. In addition, we found that the DGK is protected the esophagus in RE via suppression of pro-inflammatory protein expression and prevention of esophageal damage in an RE-induced experimental model.
Recently, studies on the use of herbal therapy in the management of reflux esophageal disease have been reported. Several studies have shown that traditional herbal was medications effectively ameliorated the histopathological signs of RE and decreased the esophageal injury index in the esophageal mucosa by regulating the expression of the inflammatory proteins and preventing the infiltration of inflammatory cells [1,3,7,18].
The geranium plant is well known as a traditional medicine to treat an inflammatory disease and it has various bioactive components. However, understanding of the varied bioactive effects such as the mechanism of the effect upon esophageal inflammation of Geranium koreanum (Geranium species) is still insufficient
LPS has been used to study induced infection, inflammation and biochemistry of inflammatory responses [30]. To demonstrate cytotoxicity and anti-inflammatory effects of different fractions, we cultured LPS-induced Raw 264.7 cells pre-treated with fraction samples were cultured for 24 h. All fractions of Geranium koreanum showed no significant cytotoxicity on Raw 264.7 cells (Figure 1b). Merely, in cells treated with EA fraction, cell viability was decreased slightly when compared with normal cells. Images of morphological changes of macrophages revealed that cell transformation in cells was increased by LPS stimulation; however, pretreatment with different fractions (especially, in the DICHO fraction) alleviated the morphological changes (Figure 1a). Base on this finding, we speculate that Geranium koreanum may be safely used as an herbal treatment for inflammatory disease.
Moreover, to determine the potential bioactivity of a solvent fraction of Geranium koreanum, we evaluated the anti-inflammatory effects by measuring the changes in the NO production and iNOS expression. During inflammatory responses, the production of pro-inflammatory mediator NO is increased by the inducible isoforms of NO synthase (iNOS) proteins [31]. In LPS-induced macrophages cells treated with DICHO fractions (at concentrations of 200 µg/mL), different fractions displayed inhibitory effects of on NO production and iNOS expression in the following order DICHO > EA > HEX > BUT (Figure 2). The inhibition of NO production and iNOS protein expression by DICHO fractions (200 µg/mL) was indicated to be higher than that by the other fractions, and we identified that DICHO fraction showed the most potent anti-inflammatory activity among the different fractions.
Esophageal mucosal damage is caused by the reflux of gastric acid and stomach contents, which is related to the inflammation process and might lead to esophageal stenosis and cancer in the esophagus [3,32]. To evaluate the protective effects of DGK on RE rats, experimental rats were orally administrated with DICHO fraction (100 and 200 mg/kg body weight). In rats, except for those in the normal control group, reflux of stomach contents and gastric acid were induced into the esophagus. In this study, an esophageal tissue of the RE control group (untreated with sample) revealed tissue damage (black and red color) and hemorrhage, which were induced by inflammation responses, compared with the normal control group. The DGK100 (100 mg/kg) group showed a decreased incidence of damage in the esophagus. In the RE + DGK200 (200 mg/kg) group, the esophageal erosions area of rats significantly decreased by more than 68% compared with the RE control group (Figure 3a–b). The results of this study indicate that the DGK has attenuated esophageal mucosa damage in acute RE rats.
Tissue damage caused by exposure to acid and stomach contents increases infiltration of inflammatory cells in the epithelium of the esophagus [13,16]. As shown in Figure 4, various histological changes such as inflammatory cell infiltrations, edema, ulceration and exfoliation of epithelial cells were observed in esophageal tissues in RE-induced rats. Recently, several research works showed that similar pathological changes such as inflammatory infiltration, edema, hyperemia, and disruption and exfoliation of epithelial layers in RE-induced rats [7,8,13,33]. These changes showed that the relationship between the esophageal epithelium and the inflammatory response is a critical in the development of the esophageal damage ratio in RE. in the Thus, it can be suggested that inflammatory processes influence the underlying mechanisms that lead to of the symptoms and tissue damages in RE. In the group of administration of DGK to RE rats, DGK ameliorated inflammatory cell infiltration, hyperemia and disruption of epithelial layers in mucosa and submucosa.
NF-κB, the main regulator of production of inflammatory proteins such as iNOS and COX-2, is activated by the cytokines tumor necrosis factor (TNF-α) and interleukin (IL)-1β during immune responses following its dissociation and phosphorylation by IκB-α. NF-κB has been reported to be involved in the expression of pro-inflammatory cytokines and proteins such as TNF-α, iNOS and COX-2 and is expressed in damaged esophagus mucosa in RE. Previous research has reported that following amelioration of esophageal damage by the extracts, the expression of inflammatory proteins was reduced in the esophagus [13]. In our study, we investigated to the expression of inflammatory biomarkers in damaged esophageal tissues to prove a relationship between esophageal mucosal damage and inflammatory responses and determine the effects of DGK. In the RE control group, the expression levels of both phosphorylated-IκB-α and phosphorylated-p65 protein were significantly increased after mucosal damage compared with the levels in a normal control group. The result of proteins level measurement showed that 100 and 200 mg/kg DGK improved the esophageal inflammation by inhibiting the expression of cytosolic p-IκB-α and nuclear p-p65 protein. In addition, DGK significantly affected the expression levels of iNOS, COX-2, TNF-α and IL-1β, especially at 200 mg/kg (Figure 5). Therefore, we demonstrated that the protective effects of DGK on mucosal damage in rats were related to regulating pro-inflammatory proteins in the esophagus.
Claudin, a tight junction protein presents not only in the epithelium but also in the endothelium, is responsible for the critical barrier function of the tight junction. In particular, claudin-4 and claudin-5 have tightening or sealing functions in tissues [6,10]. In has been reported that pro-inflammatory cytokines/chemokines such as TNF-α, IL-6 and IL-10 induced loss of claudin-5 expression in cells. The expression of claudin-4 decreased in the RE control group compared with the drug treatment groups [10,34]. We observed the effects of DGK on tight junction proteins of the damaged esophageal mucosa in the RE rat model. We found that the expression of claudin-4 and claudin-5 were all increased concentration-dependently and was significantly higher in pre-treated DGK 200 mg/kg pretreated group than in the RE control group (Figure 6). Thus, we think that these regulatory effects abilities of DGK on inflammatory reaction and sealing functions in tissues could reduce esophageal damage induced by the reflux of gastric acid.
The polyphenolic profile of the DICHO fraction of Geranium koreanum, which has beneficial bioactivity, was detected by LC-MS/MS. Geraniin is the main phenolic compound of Geranium species, and it is reported to have bioactive effects such as anti-inflammatory effects via regulation of NF-κB and Nrf2 pathways in Raw 264.7 cells, cytoprotective effect via regulation of BACH-1 and HO-1 in HepG2 cells, and anticancer effects via inhibition of NF-κB activation [10,35,36,37,38,39,40,41]. Depending on the detector counts, the phenolic compounds of DGK are displayed in Table 1. Geraniin was present in the DICHO fraction at RT 7.68 min (Figure 7). It has been identified in Geranium wilfordii Maxim., Geranium sibiricum L., Geranium robertianum L., Geranium thunbergii [38,39,40,41].
The aim of our study was to demonstrate the ameliorating effects of bioactive DGK on esophageal damage caused by RE in vivo. We identified the potent inflammatory activity of DGK through changes in inflammatory biomarker expression in LPS-induced Raw 264.7 macrophages. In the RE rat model, DGK showed a protective effect on esophageal mucosal damage and decreased inflammatory cell infiltration and epithelial loss in the mucosa. In addition, we found that the defense mechanism underlying acid reflux-induced damage involved inflammatory processes, and DGK protected the esophageal mucosa by downregulating NF-κB pathway signaling. Moreover, the expression of tight junction proteins in the esophageal mucosa showed the tendency to increase following DGK treatment in RE rats. In the analysis by LC-MS/MS, the Geraniin component detected in the DGK exerts various bioactivities. In the study, we identified the protective effects of Geranium koreanum on RE and can suggest that it could be a safe alternative therapeutic source for inflammatory diseases.

4. Materials and Methods

4.1. Chemicals

LPS, dimethyl sulfoxide (DMSO), sulfanilamide, N-(1-naphthyl) ethylene-diamine dihydrochloride (NED), hematoxylin, eosin and protease inhibitor were purchased from Sigma-Aldrich (St. Louis, MO, USA), Dulbeco’s modified eagle’s media (DMEM), Fetal bovine serum (FBS) and penicillin/streptomycin were bought from Wel Gene (St. Namchen, Gyeongsan, Korea). Cyclohexane was purchased from Bychem (Yesan-gun, Chung nam, Korea). Methylene chloride was purchased from J.T. Baker (California, CA, USA), and n-butanol and ethyl acetate were bought from Sigma-Aldrich (St. Louis, MO, USA). The ELISA kit was purchased from R&D systems (Minneapolis, MN, USA). Primary antibodies lamin B was obtained from Cell Signaling (Danvers, MA, USA). iNOS, COX-2, β-actin, TNF-α, IL-1β, claudin-4, claudin-5, phospho-IκB-α and phospho-NF-κB were purchased from Santa Cruz (Dallas, TX, USA). The secondary antibodies goat anti-rabbit, goat anti-mouse and Western blotting luminal reagent were purchased from Santa Cruz. The bovine serum albumin (BSA) protein kit was bought from Bio-Rad Laboratories (Hercules, CA, USA). Geraniin was purchased from Chengdu Biopurify Phytochemicals Ltd. (Chengdu, China).

4.2. Plant Materials and Extraction

Fresh whole plants of Geranium koreanum were collected in Gangwon-do, Korea. Harvested Geranium koreanum was cleaned with water, dried at 50 °C for 24 h, and then a sample (500 g) was extracted three times with 70% ethanol for three times in 2 h. The extract was filtered and lyophilized (IlShin, Korea) and concentrated under reduced pressure to crude extracts using a rotary evaporator. The yield (w/w %) of ethanol extract was found to be 17.3%. This crude ethanol extract (80 g) was suspended in 1 L of distilled water and partitioned into various solvents (hexane, dichloromethane, ethyl acetate and butanol). The yields (w/w %) of the fraction were found to be 6.2% (4.96 g), 2.2% (1.76 g), 1.7% (1.36 g) and 8.4% (6.72 g) respectively. Hexane fraction was referred to as HEX, dichloromethane fraction as DICHO, ethyl acetate fraction as EA and butanol fraction as BUT. All solvents for the fraction were used purified. After preparing a fraction as a stock solution was stored at −20 °C and subsequently used as a sample for measurement.

4.3. Cell Culture with Geranium Koreanum Fractions

Raw 264.7 macrophage cell line was bought from the American Type Culture Collection (ATCC, Rockville, MD, USA). Raw 264.7 cells were maintained in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin at 37 °C in a 5% CO2 incubator (SANTO, Sakata, Japan). The cells were pretreated with different concentrations (0, 100 and 200 µg/mL) of solvent fractions (HEX, DICHO, EA and BUT) for 1 h and then incubated with 1 µg/mL LPS for 24 h.

4.4. Cell Viability and Optical Morphological Transformation in Raw 264.7 Cells

To observed the impact of HEX, DICHO, EA and BUT fractions in cell viability and morphology transformation, cells were cultured in 96-well plates (1 × 106 cells/well) and 6-well plates (5 × 105 cells/well) treated with different concentrations (0, 100 and 200 µg/mL), followed by co-treatment with LPS (1 µg/mL) for 24 h at 37 °C in a 5% CO2 incubator. Cell viability was measured using a cytotoxicity assay kit, and the absorbance was measured at 540 nm using an ELISA plate reader (Multiscan Spectrum, Thermo Scientific, Vantaa, Finland). To observation of Raw 264.7 cells morphology transformation, the image of the cells was vidualized by an inverted microscope (ECLIPSE TS200, Nikon, Japan) at fixed 200× magnification.

4.5. Nitric Oxide (NO) Production in Raw 264.7 Cells

The production of NO in LPS-induced cells was measured as an indicator of NO production based on the Griess reaction. The cell culture plate conducted centrifugation process at 2500× g, 5 min. Then, 50 µL of the cell culture supernatant was mixed with 50 µL 1% sulfanilamide, and 0.1% NED incubated at 24 °C for 10 min. The absorbance at 540 nm was measured in an ELISA reader (multiscan spectrum). The amount of nitrite in the samples was determined using sodium nitrite serial dilution standard curve, and nitrite production was measured.

4.6. Animal Management

The 7-week-old Sprague dawley (SD) rats were housed according to the animal welfare regulation of the Institutional Animal Care and Use Committee (IACUC; CBNU 2017-0078) at July 24, 2017, Chonbuk National University Laboratory Animal Center, South Korea. Rats were maintained in standard rat cages at temperature (23 ± 2 °C), humidity (35~60%) and photoperiod (12-h light/dark cycle), with food and water randomly provided.

4.7. Acute RE Induction

The 30 rats (7 weeks of age) used to establish the model were fasted for 18 h prior to the RE induction surgery; however, free access to distilled water was allowed. The rats were maintained in standard laboratory conditions (temperature 23 ± 2 °C, humidity 35~60% and photoperiod cycle 12 h light and 12 h dark). The rats were anesthetized using an inhalation anesthesia. A midline laparotomy was performed to expose the upper abdomen and a 3–0 silk thread was used to ligate the junction between the pylorus and the duodenum as well as the forestomach, (only sham control rats were not ligated). Following the surgery, 30 rats were randomly divided into four groups: (1) normal control rats, (2) RE control rats, (3) RE rats treated with DGK 100 mg/kg body weight, and (4) RE rats treated with DGK 200 mg/kg body weight (Table 2). The rats in the DGK groups were treated with 100 and 200 mg/kg DICHO fraction 90 min prior to the abdominal surgery. After 5 h, the samples were collected. Esophagus samples were collected and kept in −80 °C for Western blotting analysis and immediately fixed with 10% neutral-buffered formalin (NBF) for histological analysis.

4.8. Animal Management Esophageal Lesion Ratio

The rat esophagus was cut with scissors in a longitudinal direction from the gastroesophageal junction to the pharynx after sacrifice. The inner mucous was rinsed with saline solution, and the remaining tissue was placed on white paper. Then, the dissected esophagus was photographed using an optical digital camera (Nikon, Tokyo, Japan) and the images were analyzed using the Image J program. The gross mucosal damage ratio was calculated as follows:
Gross mucosal damage ratio (%) = (width of the area with esophageal mucosal damage (mm2)/width of the total area of the esophagus (mm2)) × 100.

4.9. Histopathological Analysis of Esophageal Mucosa

Esophagus samples were excised for histopathological evaluation. Pieces of the esophagus of each rat was immediately fixed in 10% neutral-buffered formalin (NBF). After embedding in paraffin, 5-µm sections of the esophagus were stained with H-E and mounted on glass slides. Staining by hematoxylin and eosin was used to examine the histological architecture and apoptotic changes in the hepatocytes. Digital images of sample were obtained using a Leica DM2500 microscope (Leica Microsystems, Germany) at a fixed 200Xmagnification. The diameter of the portal vein was measured using image measurement software (i Solution DTM, v 22.1, Vancouver, Canada).

4.10. Preparation of Cytosol and Nuclear Fraction of Esophagus

Esophageal tissues were homogenized with ice-cold lysis buffer containing 10 mM 4-(2-Hydroxyethyl) piperazine-1-ehanesulfonic acid (HEPES) (pH 7.8), 2 mM magnesium chloride (MgCl2), 10 mM potassium chloride (KCl), and 0.1 mM ethylenediaminetetraacetic acid (EDTA), and then 1 mM dithiothreitol (DTT), 0.1 mM phenylmethylsulfonyl fluoride (PMSF) mixture solution and 10% NP-40 were added. After centrifugation (12,000× g for 2 min at 4 °C), the supernatant removed at each tube, and then the pellet was washed with distilled water. The nuclear proteins ware extracted from the esophagus, as described below. In brief, esophageal tissue was homogenized with ice-cold lysis buffer (pH 7.4) containing 50 mM HEPES (pH 7.8), 50 mM KCl, 300 mM NaCl, 1% glycerol, 0.1 EDTA, 1 mM PMSF, and protease inhibitor (PI) mixture solution. The samples were centrifuged at 12,000× g for 10 min at 4 °C. The protein concentration of each sample was measured using a Bio-Rad protein kit.

4.11. Enzyme-Linked Immunosorbent Assay (ELISA)

The levels of the pro-inflammatory cytokine IL-1β and TNF-α in the supernatants of esophagus tissue were evaluated by ELISA kits. The cytokines concentrations of the supernatant were determined in accordance with the manufacturer’s instructions and the standard curve.

4.12. Western Blot Analysis in Esophagus

The proteins extracted from the esophagus were separated by 10% and 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred from the gel to nitrocellulose membranes. The membrane was maintained with 5% skim milk in phosphate-buffered saline (PBS) solution 1% Tween 20 for 1 h at room temperature and incubated with the primary antibodies (1:1000) for overnight at 4 °C Then, the membrane incubated secondary antibodies (1:10000) at 2 h. Bands were detected using western blotting luminal reagent and images were obtained using a ChemiDocTM MP imaging system (Bio-Rad).

4.13. LC-MS/MS analysis

The phenolic compounds of DICHO isolated from Geranium koreanum analysis was performed using an ultra-performance liquid chromatography (UPLC) system (Waters, Milford, CT, USA). The conditions of LC-MS/MS analysis are provided Table 3.

4.14. Statistical Analysis

All results are expressed as mean ± SD of at least three independent experiments. Statistical analysis was performed using the statistical package of the social sciences (SPSS) software (SPSS Inc., Chicago, IL, USA) using analysis of variance (ANOVA), followed by Tukey’s multiple comparison tests. Differences were considered significant at p < 0.05

Author Contributions

B.K. conceived and designed the experiments; H.H. was performed most of experiments and wrote the manuscript; L.N was performed part of the experiments.

Funding

The study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2017R1D1A3B03036020).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Mahattanadul, S.; Ridtitid, W.; Nima, S.; Phdoongsombut, N.; Ratanasuwon, P.; Kasiwong, S. Effects of morinda citrifolia aqueous fruit extract and its biomarker scopoletin on reflux esophagitis and gastric ulcer in rats. J. Ethnopharmacol. 2011, 134, 243–250. [Google Scholar] [CrossRef] [PubMed]
  2. Yoshida, N. Inflammation and oxidative stress in gastroesophageal reflux disease. J. Clin. Biochem. Nutr. 2007, 40, 13–23. [Google Scholar] [CrossRef] [PubMed]
  3. Kim, M.Y.; Shin, Y.O.; Lee, J.Y.; Lee, A.R.; Shin, S.H.; Kwon, O.J.; Seo, B.I.; Roh, S.S. Improving effect of a combined extract of rhei rhizoma and glycyrrhizae rhizoma through anti-oxidative stress in reflux esophagitis rats. Kor. J. Herbol. 2015, 30, 37–44. [Google Scholar] [CrossRef]
  4. Meining, A.; Classen, M. The role of diet and lifestyle measures in the pathogenesis and treatment of gastroesophageal reflux disease. Am. J. Gastroenterol. 2000, 95, 2692–2697. [Google Scholar] [CrossRef] [PubMed]
  5. Yoshida, N.; Kamada, K.; Tomasturi, N.; Suzuki, T.; Takagi, T.; Ichikawa, H.; Yoshikawa, T. Management of recurrence of symptoms of gastroesophageal reflux disease: Synergistic effect of rebamipide with 15 mg lansoprazole. Dig. Dis. Sci. 2010, 55, 3393–3398. [Google Scholar] [CrossRef] [PubMed]
  6. Layli, E.; Nasseri-Moghaddam, S. Meta-analyses: Does long-term PPI use increase the risk of gastric premalignant lesions? Arch. Iran. Med. 2013, 16, 449–458. [Google Scholar]
  7. Jabri, M.A.; Tounsi, H.; Abdellaoui, A.; Marzouki, L.; Sebai, H. Protective effects of Artemisia campestris extract against gastric acid reflux-induced esophageal mucosa injuries. Pathophysiology 2018, 25, 63–69. [Google Scholar] [CrossRef] [PubMed]
  8. Lian, B.; Liu, Z.H.; Wei, H.T.; Zhang, Z.; Shi, G.N. Protection effect Xuanfudaizhetang on reflux esophagitis in rats. Asian Pac. J. Trop. Med. 2014, 7, 267–270. [Google Scholar] [CrossRef]
  9. Shin, M.R.; Seo, B.I.; Son, C.G.; Roh, S.S.; An, H.J. Banhasasim-tang treatment reduces the severity of esophageal mucosal ulcer on chronic acid reflux esophagitis in rats. BioMed Res. Int. 2017, 7157212. [Google Scholar] [CrossRef] [PubMed]
  10. Wang, P.; Qiao, Q.; Wang, J.L.; Yao, L.P.; Fu, Y.J. Inhibitory effects of geraniin on LPS-induced inflammation via regulating NF-κB and Nrf2 pathways in RAW 264.7 Cells. Chem. Biol. Interact. 2016, 253, 134–142. [Google Scholar] [CrossRef] [PubMed]
  11. Hossen, M.J.; Cho, J.Y.; Kim, D.W. PDK1 in NF-κB signaling is a target of Xanthium strumarium methanolic extract-mediated anti-inflammatory activities. J. Ethnopharmacol. 2016, 190, 251–260. [Google Scholar] [CrossRef] [PubMed]
  12. Huang, B.P.; Lin, C.H.; Chen, Y.C.; Kao, S.H. Anti-inflammatory effects of Perilla frutescens leaf extract on lipopolysaccaharide-stimulated RAW 264.7 cells. Mol. Med. Rep. 2014, 10, 1077–1083. [Google Scholar] [CrossRef] [PubMed]
  13. Souza, R.F.; Huo, X.; Mittal, V.; Schuler, C.M.; Carmack, S.W.; Zhang, H.Y.; Zhang, X.; Yu, C.; Hormi-Carver, K.; Genta, R.M.; et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology 2009, 137, 1776–1784. [Google Scholar] [CrossRef] [PubMed]
  14. Kang, J.W.; Lee, S.M. Protective effects of chlorogenic acid against experimental reflux esophagitis in rats. Biomol. Ther. 2014, 22, 420–425. [Google Scholar] [CrossRef] [PubMed]
  15. Klein, A.; Kluge, S.; Peskar, B.M. Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats. Dig. Dis. Sci. 1933, 38, 1441–1449. [Google Scholar] [CrossRef]
  16. Katada, D.; Yoschida, N.; Isozaki, Y.; Tomatsuri, N.; Ichikawa, H.; Naito, Y.; Okanoue, T.; Yoshikawa, T. Prevention by rebamipide of acute reflux esophagitis in rats. Dig. Dis. Sci. 2005, 50, 97–103. [Google Scholar] [CrossRef] [PubMed]
  17. Fitzgerald, R.C.; Onwuegbusi, B.A.; Majaj-Elliott, M.; Saeed, I.T.; Burnham, W.R.; Farthing, M.J.G. Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: Immunological determinants. Gut 2002, 50, 451–459. [Google Scholar] [CrossRef] [PubMed]
  18. Miwa, H.; Koseki, J.; Oshima, T.; Kondo, T.; Tomita, T.; Watari, J.; Matsumoto, T.; Hattori, T.; Kubota, K.; Iizuka, S. Rikkunshito, a traditional Japanese medicine, may relieve abdominal symptoms in rats with experimental esophagitis by improving the barrier function of epithelial cells in esophageal mucosa. J. Gastroenterol. 2010, 45, 478–487. [Google Scholar] [CrossRef] [PubMed]
  19. Burek, M.; Aras-Loza, P.A.; Roewer, N.; Forster, C.Y. Claudin-5 as a novel estrogen target in vascular endothelium. Arterioscler. Thromb. Vasc. Biol. 2010, 30, 298–304. [Google Scholar] [CrossRef] [PubMed]
  20. Poliak, S.; Matlis, S.; Ullmer, C.; Scherer, S.S.; Peles, E. Distinct claudins and associated PDZ proteins form different autotypic tight junctions in myelinating Schwann cells. J. Cell Ciol. 2002, 159, 361–372. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  21. Amasheh, S.; Dullat, S.; Fromm, M.; Schulzke, J.D.; Buhr, H.J.; Kroesen, A.J. Inflamed pouch mucosa possesses altered tight junctions indicating recurrence of inflammatory bowel disease. Int. J. Colorectal. Dis. 2009, 24, 1149–1156. [Google Scholar] [CrossRef] [PubMed]
  22. Jung, H.; Jun, K.H.; Jung, J.H.; Chin, H.M.; Park, W.B. The expression of claudin-1, claudin-2, claudin-3, and claudin-4 in gastric cancer tissue. J. Surg. Res. 2011, 167, e185–e191. [Google Scholar] [CrossRef] [PubMed]
  23. Sanford, J.L.; Edwards, J.D.; Mays, T.A.; Gong, B.; Merriam, A.P.; Rafael-Fortney, J.A. Claudin-5 localizes to the lateral membranes of cardiomyocytes and is altered in utrophin/dystrophin-deficient cardiomyophathic mice. J. Mol. Cell Cardiol. 2005, 38, 323–332. [Google Scholar] [CrossRef] [PubMed]
  24. Kupeli, E.; Tatli, I.I.; Akdemir, Z.S.; Yesilada, E. Estimation of antinociceptive and anti-inflammatory activity on Geranium pretense subp. Finitimum and its phenolic compounds. J. Ethopharmacol. 2007, 114, 234–240. [Google Scholar] [CrossRef] [PubMed]
  25. Oh, J.Y.; Lee, K.J.; Wei, B.; Roh, J.H.; Kang, M.; Cha, S.Y.; Jang, H.K. Antibacterial activities of bark extracts from Fraxinus rhynchophylla Hance and Geranium koreanum Kom. against clinical strains of Clostridium perfringens in chickens. Korean J. Vet. Res. 2015, 55, 117–123. [Google Scholar] [CrossRef] [Green Version]
  26. Xiao, F.; Zhai, Z.; Jiang, C.; Liu, X.; Li, H.; Qu, X.; Quyang, Z.; Fan, Q.; Tang, T.; Qin, A.; et al. Geraniin suppresses RANKL-induced osteoclastogenesis in vitro and ameliorates wear particle-induced osteolysis in mouse model. Exp. Cell Res. 2015, 330, 91–101. [Google Scholar] [CrossRef] [PubMed]
  27. Shim, J.U.; Oh, P.S.; Lim, K.T. Anti-inflammatory activity of ethanol extract from Geranium sibiricum Linne. J. Ethnopharmacol. 2009, 126, 90–95. [Google Scholar] [CrossRef] [PubMed]
  28. Lu, C.H.; Li, Y.Y.; Li, L.J.; Liang, L.Y.; Shen, Y.M. Anti-inflammatory activities fraction from Geranium nepalense and related polyphenols. Drug Discov. Ther. 2013, 6, 194–196. [Google Scholar] [CrossRef]
  29. Choo, B.K.; Roh, S.S. Berberine protects against esophageal mucosal damage in reflux esophagitis by suppressing proinflammatory cytokines. Exp. Ther. Med. 2013, 6, 663–670. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  30. Gweon, T.G.; Park, J.H.; Kim, B.W.; Choi, Y.K.; Kim, J.S.; Park, S.M.; Kim, C.W.; Kim, H.G.; Chung, J.W.; et al. Additive effects of rebamipide plus protone pump inhibitors on the expression of tight junction proteins in a rat model of gastro-esophageal reflux disease. Gut. Liver 2017, 12, 46–50. [Google Scholar] [CrossRef] [PubMed]
  31. Zong, Y.; Sun, L.; Liu, B.; Deng, Y.S.; Zhan, D.; Chen, Y.L.; He, Y.; Liu, J.; Zhang, Z.J.; Sun, J.; et al. Resveratrol inhibits LPS-induced MAPKs activation via activation of the phosphatidylinositol 3-kinase pathway murine Raw 264.7 macrophage cells. PLoS ONE 2012, 7, e44107. [Google Scholar] [CrossRef] [PubMed]
  32. Li, Y.W.; Sifrim, D.; Xie, C.; Chen, M.; Xiao, Y.L. Relationship between salivary pepsin concentration and esophageal mucosal integrity in patients with gastroesophageal reflux disease. J. Neurogastroenterol. Motil. 2017, 23, 517–525. [Google Scholar] [CrossRef] [PubMed]
  33. Hatware, K.V.; Sharma, S.; Patil, K.; Shete, M.; Karri, S.; Gupta, G. Evidence for gastroprotective, anti-infalmmatory and antioxidant potential of methanolic extract of Cordia dichotoma leaves on indomethacin and stress induced gastric lesions in Wistar rats. BioMed Pharmacother. 2018, 103, 317–325. [Google Scholar] [CrossRef] [PubMed]
  34. Liu, D.; Ma, Y.; Wang, Y.; Su, Z.; Gu, M.; Janson, J.C. One-step separation and purification of hydrolysable tannis from Geranium wilfordii Maxim by adsorption Chromatography on cross-linked 12% agarose gel. J. Sep. Sci. 2011, 34, 995–998. [Google Scholar] [CrossRef] [PubMed]
  35. Zhu, G.; Xin, X.; Liu, Y.; Huang, Y.; Li, K.; Wu, C. Geraniin attenuates LPS-induced acute lung injury via inhibiting NF-κB and activating Nrf2 Signaling pathway. Oncotarget 2017, 8, 22835–22841. [Google Scholar] [PubMed]
  36. Wang, X.; Chen, Z.; Li, X.; Jiang, Z.K.; Zhao, Y.Q.; Ping, F.F. Geraniin suppresses ovarian cancer growth through inhibition of NF-κB activation and downregulation of Mcl-1 expression. J. Biochem. Mol. Toxicol. 2017, 31. [Google Scholar] [CrossRef] [PubMed]
  37. Aayadi, H.; Mittal, S.P.K.; Deshpande, A.; Gore, M.; Ghaskadbi, S.S. Cytoprotective effect exerted by geraniin in HepG2 cells is through microRNA mediated regulation of BACH-1 and HO-1. BMB Rep. 2017, 50, 560–565. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Graca, V.C.; Barros, L.; Calhelha, R.C.; Dias, M.I.; Carvalho, A.M.; Santos-Buelga, C.; Santos, P.F.; Ferreira, I.C. Cheminal characterization and bioactive properties of aqueous and organic extracts of Geranium robertianum L. Food Funct. 2016, 7, 3807–3814. [Google Scholar] [CrossRef] [PubMed]
  39. Choi, H.J.; Choi, H.J.; Park, M.J.; Lee, J.Y.; Jeong, S.I.; Lee, S.G.; Kim, K.H.; Joo, M.S.; Jeong, H.S.; Kim, J.E.; et al. The inhibitory effects of Geranium thunbergii on imterferom-γ- and LPS-induced inflammatory responses are mediated by Nrf2 activation. Int. J. Mol. Med. 2015, 35, 1237–1245. [Google Scholar] [CrossRef] [PubMed]
  40. Wu, N.; Zu, Y.; Fu, Y.; Kong, Y.; Zhao, J.; Li, X.; Li, J.; Wink, M.; Efferth, T. Antioxidant activities and xanthine oxidase inhibitory effects of extracts and main polyphenolic compounds obtained from Geranium Sibiricum L. J. Agric. Food Chem. 2010, 58, 4737–4743. [Google Scholar] [CrossRef] [PubMed]
  41. Ctarino, M.D.; Silva, A.M.S.; Cruz, M.T.; Cardoso, S.M. Antioxidant and anti-inflammatory activities of Geranium robertianum L. decoctions. Food Funct. 2017, 8, 3355–3365. [Google Scholar] [CrossRef] [PubMed]
Ijms 19 03622 g001 550
Figure 1. Optical morphological transformation (a) and cell viability (b) of on lipopolysaccharide (LPS) (1 µg/mL)-induced Raw 264.7 cells treated with the solvent fractions (HEX—hexane, DICHO—dichloromethane, EA—ethyl acetate and BUT—butanol) of Geranium koreanum (DGK) (100 and 200 µg/mL) for 24 h. The cell viability was determined using a cytotoxicity assay kit and showed no cytotoxicity. The morphology was visualized by a light microscope at 200× magnitude. Data are means ± standard deviation (SD); * p < 0.05 compared with compared with LPS control cells.
Figure 1. Optical morphological transformation (a) and cell viability (b) of on lipopolysaccharide (LPS) (1 µg/mL)-induced Raw 264.7 cells treated with the solvent fractions (HEX—hexane, DICHO—dichloromethane, EA—ethyl acetate and BUT—butanol) of Geranium koreanum (DGK) (100 and 200 µg/mL) for 24 h. The cell viability was determined using a cytotoxicity assay kit and showed no cytotoxicity. The morphology was visualized by a light microscope at 200× magnitude. Data are means ± standard deviation (SD); * p < 0.05 compared with compared with LPS control cells.
Ijms 19 03622 g001
Ijms 19 03622 g002 550
Figure 2. Inhibition of nitric oxide (NO) production (a) Inducible nitric oxide synthase (iNOS) protein expression in LPS (1 µg/mL)-induced Raw 264.7 cells pre-treated with 100 and 200 µg/mL solvent fractions (HEX—hexane; DICHO—dichloromethane; EA—ethyl acetate; BUT—butanol) of Geranium koreanum extracts for 24 h in 5% CO2 incubator. NO production was measured using the Griess assay and the expression of iNOS protein was analyzed using the Western blotting assay. Data are means ± standard deviation (SD); ### p < 0.001 compared with normal control cells; *** p < 0.001 compared with LPS control cells.
Figure 2. Inhibition of nitric oxide (NO) production (a) Inducible nitric oxide synthase (iNOS) protein expression in LPS (1 µg/mL)-induced Raw 264.7 cells pre-treated with 100 and 200 µg/mL solvent fractions (HEX—hexane; DICHO—dichloromethane; EA—ethyl acetate; BUT—butanol) of Geranium koreanum extracts for 24 h in 5% CO2 incubator. NO production was measured using the Griess assay and the expression of iNOS protein was analyzed using the Western blotting assay. Data are means ± standard deviation (SD); ### p < 0.001 compared with normal control cells; *** p < 0.001 compared with LPS control cells.
Ijms 19 03622 g002
Ijms 19 03622 g003a 550Ijms 19 03622 g003b 550
Figure 3. Image of gross esophageal erosions area (a) and esophageal mucosal ulcer ratio (b) of acute RE rats. Normal—untreated rats; reflux esophagitis (RE) Control—RE rats; RE + DGK100—DICHO fraction of Geranium koreanum 100 mg/kg body weight treated RE rats; RE + DGK 200—DICHO fraction of Geranium koreanum 200 mg/kg body weight treated RE rats. The incidence of erosions area was significantly decreased in rats treated with DGK. Data are means ± standard deviation (SD); ## p < 0.01 and * p < 0.05 compared with normal control and RE control groups, respectively.
Figure 3. Image of gross esophageal erosions area (a) and esophageal mucosal ulcer ratio (b) of acute RE rats. Normal—untreated rats; reflux esophagitis (RE) Control—RE rats; RE + DGK100—DICHO fraction of Geranium koreanum 100 mg/kg body weight treated RE rats; RE + DGK 200—DICHO fraction of Geranium koreanum 200 mg/kg body weight treated RE rats. The incidence of erosions area was significantly decreased in rats treated with DGK. Data are means ± standard deviation (SD); ## p < 0.01 and * p < 0.05 compared with normal control and RE control groups, respectively.
Ijms 19 03622 g003aIjms 19 03622 g003b
Ijms 19 03622 g004 550
Figure 4. Hematoxylin and eosin staining of esophagus in RE rats. Normal control, reflux esophagitis (RE) control—RE + DGK 100 and RE + DGK 200 groups; Normal—untreated rats; RE Control—reflux esophagitis (RE) rats; RE + DGK100—dichloromethane fraction of Geranium koreanum 100 mg/kg body weight-treated RE rats; RE + DGK200—dichloromethane fraction Geranium koreanum 200 mg/kg body weight-treated RE rats (scale bar. 200 μM).
Figure 4. Hematoxylin and eosin staining of esophagus in RE rats. Normal control, reflux esophagitis (RE) control—RE + DGK 100 and RE + DGK 200 groups; Normal—untreated rats; RE Control—reflux esophagitis (RE) rats; RE + DGK100—dichloromethane fraction of Geranium koreanum 100 mg/kg body weight-treated RE rats; RE + DGK200—dichloromethane fraction Geranium koreanum 200 mg/kg body weight-treated RE rats (scale bar. 200 μM).
Ijms 19 03622 g004
Ijms 19 03622 g005a 550Ijms 19 03622 g005b 550
Figure 5. Inhibitory effects of DGK on inflammatory proteins and cytokines expression in esophagus. The expression levels of IL-1β (a) and TNF-α (b) in esophagus tissue were measured by enzyme-linked immunosorbent assay (ELISA). Expression of pro-inflammatory protein TNF-α, IL-1β, iNOS, COX-2, p-IκB-α, and p-p65 in esophagus tissue were measured by Western blotting (c–i). Rats were pre-treated with DGK 100 and 200 mg/kg body weight excluding normal and RE control for 90 min before surgery, which was performed under inhalation anesthesia. Then, 5 h later, the esophageal tissue was cut, and then, the was abdomen open and removed from each rat. Data are means ± standard deviation (SD). significance: ## p < 0.01 and # p < 0.05 compared with normal control group; ** p < 0.01 and * p < 0.05 compared with RE control group.
Figure 5. Inhibitory effects of DGK on inflammatory proteins and cytokines expression in esophagus. The expression levels of IL-1β (a) and TNF-α (b) in esophagus tissue were measured by enzyme-linked immunosorbent assay (ELISA). Expression of pro-inflammatory protein TNF-α, IL-1β, iNOS, COX-2, p-IκB-α, and p-p65 in esophagus tissue were measured by Western blotting (c–i). Rats were pre-treated with DGK 100 and 200 mg/kg body weight excluding normal and RE control for 90 min before surgery, which was performed under inhalation anesthesia. Then, 5 h later, the esophageal tissue was cut, and then, the was abdomen open and removed from each rat. Data are means ± standard deviation (SD). significance: ## p < 0.01 and # p < 0.05 compared with normal control group; ** p < 0.01 and * p < 0.05 compared with RE control group.
Ijms 19 03622 g005aIjms 19 03622 g005b
Ijms 19 03622 g006 550
Figure 6. Expression of tight junction proteins claudin-4 (b) and claudin-5 (c) on esophagus in RE-induced rats (a). Rats were pre-treated with 100 and 200 mg/kg body weight DGK excluding normal and RE control for 90 min before surgery, which was performed under inhalation anesthesia. Then, 5 h later, the esophageal tissue was cut, and then, the was abdomen open and removed from each rat. Data are means ± standard deviation (SD). significance: # p < 0.05 and * p < 0.05 compared with normal control and RE control groups, respectively.
Figure 6. Expression of tight junction proteins claudin-4 (b) and claudin-5 (c) on esophagus in RE-induced rats (a). Rats were pre-treated with 100 and 200 mg/kg body weight DGK excluding normal and RE control for 90 min before surgery, which was performed under inhalation anesthesia. Then, 5 h later, the esophageal tissue was cut, and then, the was abdomen open and removed from each rat. Data are means ± standard deviation (SD). significance: # p < 0.05 and * p < 0.05 compared with normal control and RE control groups, respectively.
Ijms 19 03622 g006
Ijms 19 03622 g007 550
Figure 7. Identification of Geraniin in DGK by liquid chromatography-mass spectrometry (LC-MS/MS).
Figure 7. Identification of Geraniin in DGK by liquid chromatography-mass spectrometry (LC-MS/MS).
Ijms 19 03622 g007
Table
Table 1. Identification of phytochemical compounds in DGK by LC-MS/MS.
Table 1. Identification of phytochemical compounds in DGK by LC-MS/MS.
No.Component NameNeutral Nass (Da)Observed Neutral Mass (Da)Detector CountsAdductsGroup
16′-O-Galloyl-homoarbutin438.1192438.1162149,619−HEllagitannin
2Chlorogenin432.324432.3236470,753−HGlycoside
3Markogenin432.324432.3236470,753−HGlycoside
423-Acetate alisol E532.3764532.375835,139+HCOOTriterpenoid
59,16-Dioxyhydroxy-10,12,14-triene-18 carbonic acid310.2144310.21433,679−HTerpene
6Castalagin934.0712934.072511,056−HEllagitannin
7Euphormisin M2924.0869924.088219,280+HCOO, −Htannin
8Geraniin952.0818952.083418,307−HEllagitannin
9Koryoginsenoside R1868.5184868.519514,293−HGlycoside
10Koryoginsenoside R1868.5184868.519410,068−HGlycoside
11Sanguiin H-4634.0806634.080912,355−HEllagitannin
Table
Table 2. The body weight of the 30-rat model.
Table 2. The body weight of the 30-rat model.
GroupBody Weight (g)
1Normal (n = 6)225.0 ± 4.328
2Control (n = 8)226.6 ± 2.171
3DICHO 100 mg/kg (n = 8)224.6 ± 2.104
4DICHO 200 mg/kg (n = 8)220.7 ± 2.179
Mean body weight of rats (means ± standard deviation (SD)).
Table
Table 3. The condition of LC-MS/MS analysis.
Table 3. The condition of LC-MS/MS analysis.
ParameterCondition
Ultra-performance liquid chromatography (UPLC)ACQUITY UPLC HSS T3
Column100 mm × 2.1 mm, 1.8 µm, Waters
Column temperature40 °C
Flow rate0.5 mL/min
mobile phaseA (water + 0.1% formic acid)
B (acetonitrile + 0.1% formic acid)
TimeA (%)B (%)
0973
5973
160100
170100
19973
25973
injection volume5 µL
metabolite elutedSYNAPT G2 Si HDMS QTOF (Waters),
positive and negative
positivecapillary voltage (kV)2
cone voltage (V)40
negativecapillary voltage (kV)1
cone voltage (V)40
scan range (Da)50 to 1200
scan time (s)0.2

Share and Cite

MDPI and ACS Style

Nam, H.H.; Nan, L.; Choo, B.K. Dichloromethane Extracts of Geranium Koreanum Kom. Alleviates Esophagus Damage in Acute Reflux Esophagitis-Induced Rats by Anti-Inflammatory Activities. Int. J. Mol. Sci. 2018, 19, 3622. https://doi.org/10.3390/ijms19113622

AMA Style

Nam HH, Nan L, Choo BK. Dichloromethane Extracts of Geranium Koreanum Kom. Alleviates Esophagus Damage in Acute Reflux Esophagitis-Induced Rats by Anti-Inflammatory Activities. International Journal of Molecular Sciences. 2018; 19(11):3622. https://doi.org/10.3390/ijms19113622

Chicago/Turabian Style

Nam, Hyeon Hwa, Li Nan, and Byung Kil Choo. 2018. "Dichloromethane Extracts of Geranium Koreanum Kom. Alleviates Esophagus Damage in Acute Reflux Esophagitis-Induced Rats by Anti-Inflammatory Activities" International Journal of Molecular Sciences 19, no. 11: 3622. https://doi.org/10.3390/ijms19113622

APA Style

Nam, H. H., Nan, L., & Choo, B. K. (2018). Dichloromethane Extracts of Geranium Koreanum Kom. Alleviates Esophagus Damage in Acute Reflux Esophagitis-Induced Rats by Anti-Inflammatory Activities. International Journal of Molecular Sciences, 19(11), 3622. https://doi.org/10.3390/ijms19113622

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop